According to Cognitive Market Research, the global Chymosin market size was USD 47215.2 million in 2024. It will rise at the compound annual growth rate (CAGR) of 5.00% from the year 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 18886.08 million in 2024 and will rise at a compound annual growth rate (CAGR) of 3.2% from the year 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 14164.56 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 10859.50 million in the year 2024 and will rise at a compound annual growth rate (CAGR) of 7.0% from the year 2024 to 2031.
Latin America had a market share of more than 5% of global revenue with the market size of USD 2360.76 million in 2024 and will rise at the compound annual growth rate (CAGR) of 4.4% from the year 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 944.30 million in 2024 and will rise at the compound annual growth rate (CAGR) of 4.7% from the year 2024 to 2031.
The pharmaceutical category is the fastest growing segment of the Chymosin industry
